Sagimet Biosciences (SGMT) News Today → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free SGMT Stock Alerts $4.44 +0.11 (+2.54%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024finance.yahoo.com - May 7 at 11:44 AMSagimet Biosciences Names Thierry Chauche Chief Financial Officermarketwatch.com - May 6 at 10:40 AMSagimet Biosciences Inc.: Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officerfinanznachrichten.de - May 6 at 10:40 AMSagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officerglobenewswire.com - May 6 at 8:00 AMSagimet Biosciences (NASDAQ:SGMT) Now Covered by HC Wainwrightamericanbankingnews.com - May 6 at 6:44 AMSagimet Biosciences Inc. Expected to Post Q1 2024 Earnings of ($0.41) Per Share (NASDAQ:SGMT)americanbankingnews.com - May 6 at 1:22 AMHC Wainwright & Co. Initiates Coverage of Sagimet Biosciences (SGMT) with Buy Recommendationmsn.com - May 2 at 7:59 PMSagimet Biosciences (NASDAQ:SGMT) Coverage Initiated at HC Wainwrightmarketbeat.com - May 2 at 7:23 AMSagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024globenewswire.com - April 22 at 8:00 AMShort Interest in Sagimet Biosciences Inc. (NASDAQ:SGMT) Expands By 31.3%marketbeat.com - April 13 at 8:12 PMDavid Happel Buys 12,100 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT) Stockinsidertrades.com - March 29 at 8:56 AMLeerink Partnrs Equities Analysts Boost Earnings Estimates for Sagimet Biosciences Inc. (NASDAQ:SGMT)marketbeat.com - March 29 at 8:15 AMSagimet Biosciences Inc. (NASDAQ:SGMT) CEO David Happel Acquires 12,100 Sharesmarketbeat.com - March 28 at 7:55 PMSagimet Biosciences Inc (SGMT) Reports Full Year 2023 Financial Results: A Close Lookfinance.yahoo.com - March 28 at 7:42 PMSagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstatglobenewswire.com - March 27 at 4:01 PMThe Goldman Sachs Group Trims Sagimet Biosciences (NASDAQ:SGMT) Target Price to $27.00marketbeat.com - March 26 at 2:30 PMStrong Buy Recommendation: Sagimet Biosciences’ Unique NASH Drug and Solid Financials Signal Market Growth Potentialmarkets.businessinsider.com - March 25 at 11:30 PMSagimet Biosciences: Strong Buy on Robust Financials and Promising NASH Drug Trialsmarkets.businessinsider.com - March 25 at 11:30 PMSagimet Biosciences GAAP EPS of -$2.66 beats by $34.65, revenue of $2M in-linemsn.com - March 25 at 8:27 AMSVB Leerink Initiates Coverage on Sagimet Biosciences (NASDAQ:SGMT)marketbeat.com - March 25 at 8:09 AMSagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directorsglobenewswire.com - March 25 at 7:00 AMSagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updatesglobenewswire.com - March 25 at 6:15 AMRTW Investments LP Invests $3.52 Million in Sagimet Biosciences Inc. (NASDAQ:SGMT)marketbeat.com - March 6 at 11:01 AM738,355 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Purchased by Rock Springs Capital Management LPmarketbeat.com - March 5 at 7:35 PMShort Interest in Sagimet Biosciences Inc. (NASDAQ:SGMT) Grows By 44.4%marketbeat.com - March 3 at 7:58 PMSagimet Biosciences to Participate in Two Upcoming Investor Conferencesglobenewswire.com - February 29 at 8:00 AMSagimet Biosciences Stock (NASDAQ:SGMT) Dividends: History, Yield and Datesbenzinga.com - February 25 at 8:48 PMSagimet Biosciences (SGMT) Price Target Increased by 17.19% to 51.00msn.com - February 24 at 7:46 AMPainful week for retail investors invested in Sagimet Biosciences Inc. (NASDAQ:SGMT) after 22% drop, institutions also suffered lossesfinance.yahoo.com - February 23 at 5:53 AM100,000 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Purchased by Silverarc Capital Management LLCmarketbeat.com - February 18 at 12:54 PMSagimet Biosciences Inc Class A Shares SGMTmorningstar.com - February 17 at 10:25 AMSagimet Biosciences (NASDAQ:SGMT) PT Lowered to $46.00marketbeat.com - February 7 at 11:35 AMBuy Rating Affirmed for Sagimet Biosciences as Phase 2b Results of Denifanstat Outshine Competitorsmarkets.businessinsider.com - February 7 at 12:22 AMSagimet Biosciences price target lowered by $1 at JMP Securities, here's whyrealmoney.thestreet.com - February 6 at 7:21 PMSteven Cohen's Point72 Asset Management Acquires New Stake in Sagimet Biosciences Incfinance.yahoo.com - February 6 at 2:21 PMSagimet Biosciences Announces Interim CFO Appointmentmsn.com - February 3 at 11:16 AMSagimet Biosciences Inc. (SGMT)uk.finance.yahoo.com - January 30 at 11:43 PMSagimet Biosciences prices public offering of 9M shares at $12.50 per sharemsn.com - January 26 at 10:35 AMSagimet Biosciences Announces Pricing of Public Offering of Series A Common Stockfinance.yahoo.com - January 26 at 10:35 AMSagimet Biosciences Announces Proposed Public Offering of Series A Common Stockmarkets.businessinsider.com - January 23 at 10:07 PMSagimet Biosciences Announces Proposed Public Offering of Series A Common Stockfinance.yahoo.com - January 23 at 10:07 PMSagimet Biosciences (NASDAQ:SGMT) Given New $37.00 Price Target at The Goldman Sachs Groupmarketbeat.com - January 23 at 10:39 AMSagimet Biosciences price target raised to $47 from $31 at JMP Securitiesrealmoney.thestreet.com - January 22 at 11:12 PMSagimet Biosciences Stock (NASDAQ:SGMT): Don’t Get Squeezed Out of Your Moneymsn.com - January 22 at 11:12 PMJMP Securities Boosts Sagimet Biosciences (NASDAQ:SGMT) Price Target to $47.00marketbeat.com - January 22 at 3:58 PMSagimet Biosciences Shares Rise Premarket on NASH Study Resultsmarketwatch.com - January 22 at 1:11 PMSagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASHmarkets.businessinsider.com - January 22 at 1:11 PMSagimet Biosciences Reports Positive Topline Results From Phase 2b FASCINATE-2 Study Of Denifanstatmarkets.businessinsider.com - January 22 at 1:11 PMSagimet Bio surges after mid-stage win for NASH drugmsn.com - January 22 at 1:11 PMWhy Is Fatty Liver Disease Focused Sagimet Biosciences Stock Shooting Higher Today?msn.com - January 22 at 1:11 PM Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. SGMT Media Mentions By Week SGMT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGMT News Sentiment▼0.510.37▲Average Medical News Sentiment SGMT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGMT Articles This Week▼122▲SGMT Articles Average Week Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Repare Therapeutics News Today InterCure News Today Syros Pharmaceuticals News Today PDS Biotechnology News Today Amylyx Pharmaceuticals News Today CervoMed News Today Cartesian Therapeutics News Today Coya Therapeutics News Today Karyopharm Therapeutics News Today Nuvectis Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGMT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
